12 months from date of receipt / reconstitution, 2 to 8 °C as supplied
应用 | 稀释度 | 推荐种属 |
---|---|---|
FCM | 1:2000 | Hu |
HLA-DR is a class II Major Histocompatibility Complex (MHC) antigen in human. It is primarily expressed on immune cells, especially dendritic cells and macrophages, and plays a crucial role in recognizing and distinguishing foreign substances from self-tissues. It is involved in regulating the activation status of these cells and plays a key role in immune responses, including anti-infection immunity, tumor immunity, and transplantation immunity. In organ transplantation, HLA-DR is closely related to organ transplant rejection reactions. In the fields of hematopoietic stem cell transplantation and bone marrow transplantation, HLA-DR also plays an important role. Changes in the expression level of HLA-DR are related to the diagnosis of inflammatory diseases, the assessment of severity, and the monitoring of immune status. Unlike other cell activation markers such as CD69, CD25, and CD38, HLA-DR is not expressed on most T cells and is only expressed on a subset of activated T cells during the late stages of an immune response.
Flow cytometric analysis of Human PBMC (human peripheral blood mononuclear cells) labelling Human HLA-DR antibody at1/2000 dilution (0.1 μg) (Right) compared with a Mouse monoclonal IgG isotype control (Left). Goat Anti - Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. Then cells were stained with CD19 - Alexa Fluor® 647 separately. Gated on total viable cells.